Literature DB >> 30446486

Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease.

Satoshi Kaito1, Takashi Toya1, Kota Yoshifuji1, Shuhei Kurosawa1, Kyoko Inamoto1, Kozue Takeshita2, Wataru Suda3, Kazuhiko Kakihana1, Kenya Honda2,3, Masahira Hattori3, Kazuteru Ohashi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30446486      PMCID： PMC6258918          DOI： 10.1182/bloodadvances.2018024968

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  19 in total

1.  Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease.

Authors:  Walter Spindelboeck; Eduard Schulz; Barbara Uhl; Karl Kashofer; Ariane Aigelsreiter; Wilma Zinke-Cerwenka; Adnan Mulabecirovic; Patrizia K Kump; Bettina Halwachs; Gregor Gorkiewicz; Heinz Sill; Hildegard Greinix; Christoph Högenauer; Peter Neumeister
Journal:  Haematologica       Date:  2017-02-02       Impact factor: 9.941

2.  Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.

Authors:  Kazuhiko Kakihana; Yuki Fujioka; Wataru Suda; Yuho Najima; Go Kuwata; Satoshi Sasajima; Iyo Mimura; Hidetoshi Morita; Daisuke Sugiyama; Hiroyoshi Nishikawa; Masahira Hattori; Yutaro Hino; Shuntaro Ikegawa; Keita Yamamoto; Takashi Toya; Noriko Doki; Koichi Koizumi; Kenya Honda; Kazuteru Ohashi
Journal:  Blood       Date:  2016-07-26       Impact factor: 22.113

3.  Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection.

Authors:  Matthew J Hamilton; Alexa R Weingarden; Michael J Sadowsky; Alexander Khoruts
Journal:  Am J Gastroenterol       Date:  2012-01-31       Impact factor: 10.864

4.  Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  Ying Taur; Joao B Xavier; Lauren Lipuma; Carles Ubeda; Jenna Goldberg; Asia Gobourne; Yeon Joo Lee; Krista A Dubin; Nicholas D Socci; Agnes Viale; Miguel-Angel Perales; Robert R Jenq; Marcel R M van den Brink; Eric G Pamer
Journal:  Clin Infect Dis       Date:  2012-06-20       Impact factor: 9.079

5.  What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score.

Authors:  Margaret L MacMillan; Todd E DeFor; Daniel J Weisdorf
Journal:  Br J Haematol       Date:  2012-04-06       Impact factor: 6.998

Review 6.  First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

Authors:  Paul J Martin; J Douglas Rizzo; John R Wingard; Karen Ballen; Peter T Curtin; Corey Cutler; Mark R Litzow; Yago Nieto; Bipin N Savani; Jeffrey R Schriber; Paul J Shaughnessy; Donna A Wall; Paul A Carpenter
Journal:  Biol Blood Marrow Transplant       Date:  2012-04-14       Impact factor: 5.742

7.  Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

Authors:  Ilan Youngster; George H Russell; Christina Pindar; Tomer Ziv-Baran; Jenny Sauk; Elizabeth L Hohmann
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

8.  Loss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant.

Authors:  Joshua Stripling; Ranjit Kumar; John W Baddley; Anoma Nellore; Paula Dixon; Donna Howard; Travis Ptacek; Elliot J Lefkowitz; Jose A Tallaj; William H Benjamin; Casey D Morrow; J Martin Rodriguez
Journal:  Open Forum Infect Dis       Date:  2015-06-03       Impact factor: 3.835

9.  Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.

Authors:  C Castilla-Llorente; P J Martin; G B McDonald; B E Storer; F R Appelbaum; H J Deeg; M Mielcarek; H Shulman; R Storb; R A Nash
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

10.  Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection.

Authors:  Ilan Youngster; Jasmin Mahabamunuge; Hannah K Systrom; Jenny Sauk; Hamed Khalili; Joanne Levin; Jess L Kaplan; Elizabeth L Hohmann
Journal:  BMC Med       Date:  2016-09-09       Impact factor: 8.775
View more
  22 in total

1.  Safety and efficacy of fecal microbiota transplantation in the treatment of graft-versus-host disease.

Authors:  Xiaoying Qiao; Jarosław Biliński; Leyi Wang; Tianyu Yang; Rongmu Luo; Yi Fu; Guibin Yang
Journal:  Bone Marrow Transplant       Date:  2022-09-27       Impact factor: 5.174

2.  [How I treat gastrointestinal tract acute graft versus host disease with fecal microbiota transplantation].

Authors:  X W Tang; D P Wu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-05-14

Review 3.  Microbiota modification in hematology: still at the bench or ready for the bedside?

Authors:  Christopher J Severyn; Ryan Brewster; Tessa M Andermann
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 4.  The role of microbiota in allogeneic hematopoietic stem cell transplantation.

Authors:  Chia-Chi Chang; Eiko Hayase; Robert R Jenq
Journal:  Expert Opin Biol Ther       Date:  2021-01-18       Impact factor: 5.589

Review 5.  Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome.

Authors:  Avner Leshem; Nir Horesh; Eran Elinav
Journal:  Front Immunol       Date:  2019-06-14       Impact factor: 7.561

Review 6.  Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients.

Authors:  H R Wardill; K R Secombe; R V Bryant; M D Hazenberg; S P Costello
Journal:  EBioMedicine       Date:  2019-03-30       Impact factor: 8.143

Review 7.  Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation.

Authors:  Daniele Zama; Gianluca Bossù; Davide Leardini; Edoardo Muratore; Elena Biagi; Arcangelo Prete; Andrea Pession; Riccardo Masetti
Journal:  Ther Adv Hematol       Date:  2020-01-20

8.  Continuous pre- and post-transplant exposure to a disease-associated gut microbiome promotes hyper-acute graft-versus-host disease in wild-type mice.

Authors:  Kate L Bowerman; Antiopi Varelias; Nancy Lachner; Rachel D Kuns; Geoffrey R Hill; Philip Hugenholtz
Journal:  Gut Microbes       Date:  2020-01-13

Review 9.  Microbiota modification in hematology: still at the bench or ready for the bedside?

Authors:  Christopher J Severyn; Ryan Brewster; Tessa M Andermann
Journal:  Blood Adv       Date:  2019-11-12

Review 10.  Treatment and unmet needs in steroid-refractory acute graft-versus-host disease.

Authors:  Florent Malard; Xiao-Jun Huang; Joycelyn P Y Sim
Journal:  Leukemia       Date:  2020-04-03       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.